Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07290140 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Study acronym: RESTORE-2 RCT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 8 to 10v4
  2. Trial sites expanded: 1 → 8 locationsv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2026 to Jun 1, 2026
    • Study site revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, multicenter, randomized, controlled, double-blind clinical trial enrolling 300 adult subjects with chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP) indicated for endoscopic sinus surgery (ESS).
Trial Details
NCT Number NCT07290140
Lead Sponsor Airiver Medical, Inc.
Conditions
(from sponsor)		 Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov